• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GXE:GR

12.665 EUR 0.065 0.51%

As of 09:05:02 ET on 08/29/2014.

Snapshot for Galapagos NV (GXE)

Open: 12.800 Day's Range: 12.560 - 12.950 Volume: 2,530
Previous Close: 12.730 52wk Range: 11.940 - 18.230 1-Yr Rtn: -14.32%

Stock Chart for GXE

No chart data available.
  • GXE:GR 12.665
  • 1D
  • 1M
  • 1Y
12.730
Interactive GXE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GXE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.9440
Est. PEG Ratio -
Market Cap (M EUR) 383.50
Shares Outstanding (M) 30.28
30 Day Average Volume 128
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GXE

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GXE

Galapagos NV is a drug discovery company focused on the identification of disease modifying drug targets. The Company specializes in osteoporosis, rheumatoid arthritis, osteoarthritis and Alzheimer's disease.

Onno Van De StolpeCEO/Executive DirectorLaure VerhaegenInterim CFO/VP:Finance
Piet WigerinckChief Scientific OfficerDavid SmithCEO:Service Division
More Company Profile & Key Executives for GXE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil